Your search matched 285 results
The Week That Was: No Rest for the Wicked | Blog
We’ve recapped Scott Gottlieb’s eventful penultimate week at the FDA in this week’s edition of The Week That Was.
The Week That Was: Green, Red, White and Blue | Blog
This week's edition of The Week That Was details how health and medical groups are taking action to address the “greatest public health challenge of the 21st century” and what you need to know from a busy week in healthcare policy.
The Week That Was: Tik Tok Don’t Stop | Blog
In this week’s edition of The Week That Was, we analyze recent public apologies.
The Week That Was: A Whole Lotta Firsts | Blog
Funding for federal gun violence research and an early holiday present for biosimilars manufacturers -- We break down the new federal budget as well as news from the ACA’s legal saga in this week’s edition of The Week That Was.
The Week That Was: That LaLa feeling | Blog
This week’s edition of The Week That Was looks at how not to spin a poor earnings report.
The Week That Was: To Infinity and Beyond | Blog
In this week’s edition of The Week That Was, we dig into the Administration’s plan, the debate over the policy and what’s next.
The Week That Was: Got Meth or a Bonus? | Blog
Read about this and much more in this week’s edition of The Week That Was.
The Week That Was: Nowhere Left To Go | Blog
We’ve analyzed their progress in this week’s issue of The Week That Was.
The Week That Was: Full-Speed- Ahead Fall | Blog
Check out our take on which policies could move in this week’s edition of The Week That Was.
The Week That Was: Flying Cat-a-strophe | Blog
We dig into how Boeing leaders are working to rebuild their reputation and more in this week’s edition of The Week That Was.
The Week That Was: Farewell, Yellow Brick Road | Blog
In this week’s edition of The Week That Was, we explain one way they can communicate value.
The Week That Was: 20 Hours of in-flight fun? | Blog
Learn why not all PR is good PR in this week’s edition of The Week That Was.
The Week That Was: Bearing the Market and Blowing the Whistle | Blog
Check out this week’s edition of The Week That Was.
The Week That Was: Profits and Plagues | Blog
This week’s edition of The Week That Was details how the Business Roundtable’s “Statement on the Purpose of a Corporation” shifts businesses’ focus from solely shareholders to all stakeholders.
The Week That Was: No shortage of highs | Blog
Read about the hearing in this week’s edition of The Week That Was.
The Week That Was: Riding the Blues | Blog
We dig into their reputation repair campaign and how it’s impacting the competition in this week’s The Week That Was.
The Week That Was: Hiccups, ICER and IPI | Blog
We dig into this and more in this week’s edition of The Week That Was.
The Week That Was: Where Have All the Unicorns Gone? | Blog
Nancy Pelosi’s highly anticipated drug pricing plan to risk-adverse investors, our team shares the latest on the healthcare environment in this week’s edition of The Week That Was.
The Week That Was: Walking on Mars | Blog
In this week’s edition of The Week That Was we discuss the current situation and what may be coming for the healthcare industry.
A busy week in Washington | Blog
So, a lot happened in Washington this week… which we won’t be commenting on!
The Week That Was: High Times at CVS | Blog
We’re talking CBD in this week’s edition of The Week That Was.
The Week That Was: I do, Ms. | Blog
In this week’s edition of The Week That Was, we discuss the rule, the reactions and what it means for patients, providers and pharma.
The Week That Was: From IPO to Tomato | Blog
Our team digs into the life sciences IPO market and what to watch in this week’s edition of The Week That Was.
The Week That Was: A Less Sharp FDA? | Blog
This week’s edition of The Week That Was takes a look and provides insights from a new ICER report.
Question of the Week: Who’s Responsible for Addiction? | Blog
Read this and more in this week's TWTW!
The Week That Was: Re-Wear Your Happy Hat | Blog
We’ve got a recap for you in this week’s edition of The Week That Was.
The Week That Was: Dude, where’s my paycheck? | Blog
Take a look at the latest insights in this week’s issue of The Week That Was.
The Week That Was: Could President Barbie Take on Drug Pricing? | Blog
In this week’s edition of The Week That Was, we analyze the possible implications a presidential impeachment would have on drug pricing policy.
The Week That Was: The word of the year: “They” | Blog
We detail the bill and what it could mean for life sciences companies in this week's edition of The Week That Was.
Already have a RSS feed reader?
